Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Coherus Oncology, Inc.CHRS · Entity 6276 | Director | June 03, 2024 | June 05, 2024 |
| RTI SURGICAL, INC.RTIX · Entity 159205 | Director | March 08, 2019 | March 11, 2019 |
| RadNet, Inc.RDNT · Entity 3800 | EVP, Chief Financial Officer | March 03, 2026 | March 05, 2026 |
| SURGALIGN HOLDINGS, INC.SRGA · Entity 109633 | Director | August 15, 2022 | August 17, 2022 |
| Starling Oncology, Inc.TOI · Entity 5327 | Director | July 27, 2026 | July 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Coherus Oncology, Inc.
Report date June 03, 2024 · Filed June 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.76 · Expires 2034-06-03 | Direct | 112,000 |
Reported balance
After 2024-06-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-03 · Grant · Acquired 112,000 · Balance 112,000 F1: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.
RTI SURGICAL, INC.
Report date March 08, 2019 · Filed March 11, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 1
1 source rowRow 1 · 2019-03-08 · Disposition to issuer · Disposed 66,784 · Balance 0 F1: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc." F2: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger. F3: The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers. F4: Total includes 21,322 shares of restricted stock that will vest on 2/26/2020. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc."
F2: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger.
F3: The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers.
F4: Total includes 21,322 shares of restricted stock that will vest on 2/26/2020.
RadNet, Inc.
Report date March 03, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 121,943 |
Reported balance
After 2026-03-03 transaction · row 1
1 source rowRow 1 · 2026-03-03 · Grant · Acquired 18,228 · Balance 121,943 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock. Amount reported is net of 1,060 restricted stock awards transferred pursuant to a domestic relations order. Subject to the reporting person's continued service, twenty-percent (20%) of the RSUs will vest on March 10, 2026; the remaining eighty-percent (80%) will vest in three equal annual installments with one-third (1/3) vesting on each of March 10, 2027, 2028, and 2029, or the first business day thereafter if such date falls on a weekend or holiday, respectively. RDNT shares will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of RadNet, or (iv) in equal annual installment payments over five years beginning on January 10, 2028. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock. Amount reported is net of 1,060 restricted stock awards transferred pursuant to a domestic relations order. Subject to the reporting person's continued service, twenty-percent (20%) of the RSUs will vest on March 10, 2026; the remaining eighty-percent (80%) will vest in three equal annual installments with one-third (1/3) vesting on each of March 10, 2027, 2028, and 2029, or the first business day thereafter if such date falls on a weekend or holiday, respectively. RDNT shares will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of RadNet, or (iv) in equal annual installment payments over five years beginning on January 10, 2028.
SURGALIGN HOLDINGS, INC.
Report date August 15, 2022 · Filed August 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,867 |
Reported balance
After 2022-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-08-15 · Grant · Acquired 22,857 · Balance 28,867 F1: Represents shares of restricted stock of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. F2: The total shares reported reflect 1:30 reverse stock split on May 17, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of restricted stock of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant.
F2: The total shares reported reflect 1:30 reverse stock split on May 17, 2022.
Starling Oncology, Inc.
Report date July 27, 2026 · Filed July 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,957 |
Reported balance
After 2026-07-27 transaction · row 1
1 source rowRow 1 · 2026-07-27 · Grant · Acquired 31,124 · Balance 56,957 F1: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2018 Filed Mar 1, 2018 12:28 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantCommon Stock | 17,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001100441-18-000001 · primary_doc.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,462 F1 · shares: Represents shares of restricted stock of RTI Surgical, Inc. (the "Company") granted to Mr. Stolper as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 01:52 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 21,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-18-000025 · stolper_f4.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,065 Underlying: Common Stock · 21,564 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of RDNT common stock. F3 · derivative.exercise_date: The RSUs vest Jan. 2, 2023. Shares will be delivered to the reporting person in exchange for vested RSUs on Jan 2, 2023. F3 · derivative.expiration_date: The RSUs vest Jan. 2, 2023. Shares will be delivered to the reporting person in exchange for vested RSUs on Jan 2, 2023. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 01:52 UTC | RadNet, Inc. RDNT · Entity 3800 | OtherStock Options · Derivative | 21,564 | Not disclosed Strike: $10.05 | Not disclosed |
DisclosureSEC source: 0001683168-18-000025 · stolper_f4.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,666 Underlying: Common Stock · 21,564 shares Expires 2028-01-02 F1 · price: Issued in connection with retention of employment. Vests 1/3 on first anniversary and 1/3 on each anniversary thereafter. Read SEC document |
| August 30, 2017 Filed Aug 30, 2017 21:16 UTC | RadNet, Inc. RDNT · Entity 3800 | SaleCommon Stock | 10,000 | $10.19 | $101,900.00 |
DisclosureSEC source: 0001683168-17-002257 · stolper_f4.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,319 Read SEC document |
| May 24, 2017 Filed May 24, 2017 20:47 UTC | RadNet, Inc. RDNT · Entity 3800 | SaleCommon Stock | 15,000 | $7.33 | $109,950.00 |
DisclosureSEC source: 0001683168-17-001397 · stolper_f4.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,319 Read SEC document |
| May 16, 2017 Filed May 17, 2017 12:38 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantCommon Stock | 16,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001100441-17-000012 · primary_doc.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,815 F1 · shares: Represents shares of restricted stock of RTI Surgical, Inc. (the "Company")granted to Mr. Stolper as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. Read SEC document |
| May 05, 2017 Filed May 9, 2017 12:15 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | PurchaseCommon Stock | 5,000 | $4.57 | $22,850.00 |
DisclosureSEC source: 0001100441-17-000011 · primary_doc.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,331 F1 · shares: Purchased on open market. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 14:00 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantCommon Stock | 6,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001100441-17-000008 · primary_doc.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,331 F1 · shares: Represents shares of restricted stock of RTI Surgical, Inc.(the Company) granted to Mr. Stolper as part of the director compensation program of the Company, all of which will vest on July 6, 2017. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 17:41 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 34,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-17-000043 · stolper_f4.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,501 Underlying: Common Stock · 34,399 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of RDNT common stock. F3 · derivative.exercise_date: The RSUs vest Jan. 6, 2022. Shares will be delivered to the reporting person in exchange for vested RSUs on Jan 6, 2022. F3 · derivative.expiration_date: The RSUs vest Jan. 6, 2022. Shares will be delivered to the reporting person in exchange for vested RSUs on Jan 6, 2022. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 17:41 UTC | RadNet, Inc. RDNT · Entity 3800 | OtherStock Options · Derivative | 34,399 | Not disclosed Strike: $6.30 | Not disclosed |
DisclosureSEC source: 0001683168-17-000043 · stolper_f4.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,102 Underlying: Common Stock · 34,399 shares Expires 2027-01-06 F1 · price: Issued in connection with retention of employment. Vests 1/3 on first anniversary and 1/3 on each anniversary thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.